IVMED OVO

Preimplantation Genetic Testing (PGT)

Preimplantation Genetic Testing (PGT) is a modern reproductive technology that evaluates the genetic health of embryos before transfer into the uterus. It reduces the risk of passing genetic or chromosomal disorders, increases IVF effectiveness, lowers miscarriage rates, and improves the chances of having a healthy child.

How the program works

We help couples achieve pregnancy with embryos that are genetically tested, reducing risks and improving outcomes

1

1

Initial examination

Both partners undergo standard IVF testing (hormonal analysis, infection screening, semen analysis, ovarian reserve tests, ultrasound, and specialist consultations).

2

2

IVF cycle and embryo development

Eggs are retrieved and fertilized with sperm, then cultured in the lab until the blastocyst stage (day 5–6).

3

3

Embryo biopsy

A few cells are taken from the embryo’s outer layer without affecting development. Genetic testing: Biopsied cells are analyzed to detect abnormalities. Only embryos with normal results are selected for transfer.

4

4

Genetic testing

Biopsied cells are analyzed to detect abnormalities. Only embryos with normal results are selected for transfer.

5

5

Embryo transfer or freezing

Healthy embryos are either transferred into the uterus or frozen for future use.

Countries for treatment

For your convenience, we offer IVF programs in different countries, each with its own advantages and limitations

Slovakia

Embryo transfer is possible in the uterine cavity of a woman up to 53 years old.

Spain

Embryo transfer is possible in the uterine cavity of a woman under the age of 51.

Guaranteed programs available

For couples who are married or in a relationship (including a civil marriage).

Georgia

Embryo transfer is possible in the uterine cavity of a woman under the age of 54.

Guaranteed programs available

Surrogacy programs available

F.A.Q.

Get answers to common questions about our IVF program

  • PGT-A (Aneuploidy testing): Detects abnormal chromosome numbers (e.g., Down, Edwards, Patau syndromes, X/Y disorders).
  • PGT-M (Monogenic disease testing): Identifies specific genetic mutations when one or both partners are carriers of inherited diseases (e.g., cystic fibrosis, SMA, Huntington’s disease, Marfan syndrome).
  • PGT-SR (Structural rearrangements): Used when a parent has chromosomal rearrangements (inversions, translocations) that could cause miscarriage or congenital disorders.
  • No test can give a 100% guarantee. PGT significantly reduces risks but does not eliminate all genetic or medical conditions.

    Yes, when performed by experienced specialists, embryo biopsy is considered safe and does not affect the chances of implantation.

    Yes, PGT can be performed on embryos created with donor material, if required.

    Was this information helpful?

    Medically Reviewed by:

    Dr. Kateryna Kasian

    MD, obstetrician-gynecologist

    Last Updated:

    January 27, 2026

    Was this helpful?

    Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for personalized medical guidance and treatment recommendations.

    Scroll to Top

    Contact Us

    Send a message

    We’re happy to hear from you! If you have any questions or suggestions, please fill out the form below, and we’ll get back to you as soon as possible.